Rexahn Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Rexahn Pharmaceuticals Inc
TickerIRD
CIK #0001228627
CUSIP67577R102
SectorLife Sciences - Pharmaceutical Preparations
Address15245 Shady Grove Road, Suite 455, Rockville, MD 20850
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Opus Genetics Inc 2024-11-07 25.8 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Ocuphire Pharma Inc 2020-11-20 21.1 M Exemption: 506(b) · Duration: One year or less · Commission: $1,600,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001228627] 10-K
[0001228627] 10-Q
[0001228627] 3
[0001228627] 4
[0001228627] 5
[0001228627] 8-K
[0001228627] D
[0001228627] SC 13D
[0001228627] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Caligan Partners LP Opus Genetics Inc [2026-05-15] 0.0
Adage Capital Management LP Opus Genetics Inc [2026-05-13] 0.0
Balyasny Asset Management LP Opus Genetics Inc [2026-02-17] 0.0
BIOS Fund III LP Opus Genetics Inc [2025-08-11] 0.0
Nantahala Capital Management LLC Opus Genetics Inc [2025-05-15] 0.0
Perceptive Advisors LLC Opus Genetics Inc [2025-03-31] 0.0
Foundation Fighting Blindness Retinal Degeneration Fund Opus Genetics Inc [2024-10-29] 81948.16
Richmond Brothers Inc Ocuphire Pharma Inc [2022-05-17] 5.84
Apexian Pharmaceuticals Inc Ocuphire Pharma Inc [2021-03-26] 7.136
Sooch Mina Ocuphire Pharma Inc [2021-03-17] 11.8
Altium Capital Management LP Ocuphire Pharma Inc [2020-11-16] 8.3
Richmond Brothers Inc Ocuphire Pharma Inc [2020-11-16] 1.0
Empery Asset Management LP Ocuphire Pharma Inc [2020-11-12] 7.58
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2020-08-10] 1.0
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2019-02-05] 4.99
Anson Funds Management LP Rexahn Pharmaceuticals Inc [2018-10-29] 5.1
CVI Investments Inc Rexahn Pharmaceuticals Inc [2018-10-26] 5.1
Sabby Management LLC Rexahn Pharmaceuticals Inc [2016-02-29] 4.89
Empery Asset Management LP Rexahn Pharmaceuticals Inc [2015-11-10] 8.44
Sabby Management LLC Rexahn Pharmaceuticals Inc [2012-12-04] 6.41
Form 3/4/5 Filer 2011 - 2026
Foundation Fighting Blindness Inc
Foundation Fighting Blindness Retinal Degeneration Fund
Rexahn Pharmaceuticals Inc
Magrath George
Jayagopal Ashwath
Zaremba Rabourn Amy
Yerxa Benjamin R
Gagnon Robert E
Schachle Joseph K
Bennett Jean
Benton Susan
Gallagher Cam
Graves Adrienne L
Manuso James S J
Rodgers Richard J
Ainsworth Sean
Hoffmann Bernhard
Jhaveri Nirav S
Pepose Jay
Patel Ronil A
Sooch Mina
Meyer Alan R
Sullivan Lara
Brandt Peter C
Price Ben Gil
Beever Charles
Cheong Kwang Soo
Nolan Lisa
Benaim Ely
Swirsky Douglas J
Suzdak Peter David
Ahn Chang Ho
Carthy Mark
Jeong Tae Heum
Hwang Si Moon
McIntosh David M
Soni Rakesh
Kivel Richard
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Magrath George
Common Stock
2026-03-16 Sell 24,438 $5.21 127,322
Schachle Joseph K
Common Stock
2026-03-16 Sell 3,719 $5.25 19,525
Jayagopal Ashwath
Common Stock
2026-03-16 Sell 3,719 $5.12 19,041
Zaremba Rabourn Amy
Common Stock
2026-03-16 Sell 2,816 $5.25 14,784
Jayagopal Ashwath
Common Stock
2026-02-12 Tax withheld 5,313 $3.39 18,011
Zaremba Rabourn Amy
Common Stock
2026-01-22 Grant 86,500 $0.00
Schachle Joseph K
Common Stock
2026-01-22 Grant 250,000 $0.00
Yerxa Benjamin R
Common Stock
2026-01-22 Grant 400,000 $0.00
Magrath George
Common Stock
2026-01-22 Grant 483,639 $0.00
Gagnon Robert E
Common Stock
2026-01-22 Grant 400,000 $0.00
Jayagopal Ashwath
Common Stock
2026-01-22 Grant 400,000 $0.00
Zaremba Rabourn Amy
Common Stock
2026-01-18 Tax withheld 3,390 $2.10 7,119
Zaremba Rabourn Amy
Common Stock
2026-01-10 Tax withheld 3,950 $1.93 7,624
Gallagher Cam
Common Stock
2026-01-06 Grant 67,000 $0.00
Graves Adrienne L
Common Stock
2026-01-01 Grant 23,643
Ainsworth Sean
Common Stock
2026-01-01 Grant 42,507
Manuso James S J
Common Stock
2026-01-01 Grant 31,188
Bennett Jean
Common Stock
2026-01-01 Grant 21,127
Gallagher Cam
Common Stock
2025-12-31 Grant 33,000 $0.00
Gallagher Cam
Common Stock
2025-12-29 Buy 81,000 $1.98 160,380
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 79 45,469,735
2025-12-31 59 27,858,568
2025-09-30 48 19,036,304
2025-06-30 45 17,637,556
2025-03-31 47 14,575,016
2024-12-31 44 3,693,276
2024-09-30 39 2,546,502
2024-06-30 37 2,700,102
2024-03-31 49 3,532,945
2023-12-31 50 3,796,396
2023-09-30 51 3,825,350
2023-06-30 53 3,958,843
Form 13F Holdings
Firm Period DFND Voting Shares
First City Capital Management Inc [2026-06-30] SOLE 0 11,836
Farther Finance Advisors LLC [2026-06-30] SOLE 0 3,490
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com